March 2022 |
Boston Globe/Stat News, 24 March 2022
Despite competition, US cancer drug prices rose even as they fell in Germany and Switzerland
|
January 2022 |
SRF Echo der Zeit, January 30th, 2022
Firmen wollen Hürden für den EU-Export umgehen
|
|
SRF Tagesschau, January 26th 2022
Sicherheitslücke im Kundenportal des Schwarzfahrer-Registers
|
December 2021 |
Le Temps, December 11th, 2021
Les capsules destinées au suicide légales en Suisse? Pas si simple
|
|
NZZ, December 8th, 2021
Aktivisten sehen keine juristischen Hindernisse für einen Einsatz der Suizidkapsel in der Schweiz – doch es gibt grosse Zweifel am «Tesla der Sterbehilfe»
|
|
SRF, December 4th, 2021
Impfpflicht in der Schweiz? Fünf Fragen und Antworten
|
November 2021 |
SRF, November 19th, 2021
Expertin: «Genereller Impfzwang in der Schweiz nicht möglich»
|
September 2021 |
Business Insider, September 10th, 2021
One key study highlights how cancer-drug prices continue to rise in the US - even if they don't elsewhere
|
|
NZZ, September 2nd, 2021
Bei keiner anderen Krankheit wird so viel für Medikamente ausgegeben wie bei Krebs. Warum eigentlich?
|
August 2021 |
SRF, August 26th, 2021
Spaltet das Covid-Zertifikat die Gesellschaft? SRF 10 vor 10
|
July 2021 |
NZZ, July 28th, 2021
Masken nur noch für ungeimpfte Schüler? Die Politik hat die Bedeutung des Covid-Zertifikats unterschätzt und solche Aspekte nicht geregelt
|
July 2021 |
NZZ, July 3rd, 2021
Medikamente sind teuer - selbst wenn sie kaum wirken
|
July 2021 |
STAT News / Boston Globe, July 1st, 2021
U.S. cancer drug prices were higher at launch than in three European countries — and just kept climbing
|
April 2021 |
SRF 10 vor 10, April 22nd, 2021
Covid-Zertifikat: Staatsrechtlerin fordert breite Diskussion
|
|
NZZ, April 17th, 2021
Die Schweizer Pharmaforschung schwächelt bei der Digitalisierung
|
|
STAT News / Boston Globe, April 13th, 2021
Link: Europe tries to lower drug prices with small doses of transparency
PDF: Europe tries to lower drug prices with small doses of transparency (PDF, 290 KB)
|
|
WIRED, April 12th, 2021
This AI could help wipe-out colon cancer
|
February 2021 |
Swissinfo, February 19th, 2021
Secret discounts leave patients at drugmakers' mercy |
|
Rundschau (SRF), February 17th, 2021
Medikamentenpreise werden immer häufiger zur Geheimsache
Blackbox Medi-Preis: Geheime Pharma-Verhandlungen
|
January 2021
|
NZZ, January 19th, 2021
Künstliche Intelligenz erkennt Covid-19 am Geräusch
|
October 2020 |
New York Times, October 29th, 2020
Gilead’s Covid-19 Drug is Mediocre. It Will Be a Blockbuster Anyway
|
September 2020 |
Nature Outlook, September 23rd, 2020
Research round-up: Precision oncology
|
Mai 2020 |
Swissinfo, Mai 1st, 2020
Swiss Study Sees No Link Between Cancer Drug Prices and Patient Benefits
|
January 2020 |
Los Angeles Times, January 3rd, 2020
Artificial intelligence has come to medicine. Are patients being put at risk?
|
December 2019
|
NZZ am Sonntag, December 29th, 2019
Tödliche Lotterie für Krebskranke: Patienten müssen immer länger auf neue Medikamente warten |
|
Scientific American, December 24th, 2019
Artificial intelligence is rushing into patient care—and could raise risks
|
|
Plädoyer, December 2nd, 2019
Interessante Schnittstelle zwischen Recht und Medizin
|
November 2019 |
Rundschau (SRF), November 20th, 2019
Teure Krebsmedikamente
|
September 2019
|
European Society for Medical Oncology, September 29th, 2019
New Studies Question Whether Novel Anti-Cancer Drugs Are Worth Their Extra Cost
|
|
Weltwoche, September 4th, 2019
Kopf der Woche: Kerstin Vokinger
|
|
Higgs, September 4th, 2019
Die Anonymisierung in Gerichtsurteilen bringt nichts
|
|
Forbes, September 3rd, 2019
Researchers Use Big Data And AI To Remove Legal Confidentiality
|
|
Tagesschau (SRF), September 2nd, 2019
So können Anonymisierungen in Gerichtsurteilen aufgehoben werden
|
January 2019 |
Business Insider, January 14th, 2019
Medicare changes could have some patients paying more for drugs
|
|
Channel News Asia, January 14th, 2019
Medicare changes could have some patients paying more for drugs
|
December 2018 |
Plädoyer, December 3rd, 2018
In dubio pro Krankenkasse
|
October 2018 |
PracticeUpdate, October 22nd, 2018
ESMO 2018: Highest Benefit Cancer Drugs Receive Faster Approval in European Union
|
|
Cancerworld, October 21st, 2018
Reimbursement of newly approved cancer drugs may take more than one year
|
|
Science Daily, October 19th, 2018
Securing access to optimal cancer care through innovation, integration and sustainability
|
|
Health Economics, October 19th, 2018
Times Vary Widely on Reimbursement Decisions for New Cancer Drugs in EU
|
September 2018 |
Tagesanzeiger, September 29th, 2018
Gewinner sind fast immer die Krankenkassen
|